In the 20 years since the world first heard of AIDS (acquired immunodeficiency syndrome), which HIV (human immunodeficiency virus ) is known to be the etiologic agent, the epidemic has spread rapidly to most parts of the world and brought about a disaster to human health.
The pathological manifestations of cytomegalovirus (CMV) infection in 51 autopsy cases with acquired immunodeficiency syndrome (AIDS) including 43 males and 8 females with an average age of 38. 6 years are reported.
This study lays emphasis on reviewing two risk behaviors related AIDS, i.e. drug taking with shared injectors and insecure sexual behaviors, and consequently working out intervention strategies and measures, in order to make an appeal for medical experts to join in our efforts in preventing and controlling AIDS.
PPD test negative rate is higher, X-ray film is atypical , Disease situation is more complex, treatment result is no good, fatality rate is higher that pulmonary tuberculosis related AIDS than only pulmonary tuberculosis.
We designed an isatin lead compound as a novel non-nucleoside reverse transcriptase inhibitor with broad-spectrum chemotherapeutic properties for the effective treatment of AIDS and AIDS-related opportunistic infections.
It is an essential enzyme required for replication of the acquired immunodeficiency syndrome (AIDS) virus.
This result greatly aids in solving the integer optimization problem and yields the first approximation for the solution of the dual problem.
This approach aids in analyzing documents with badly defined information.
This approach aids in constructing a transformation for reducing the initial problem to a boundary-value problem for slow variables and two initial-value problems for fast variables.
In recent years, significant progress has been made towards the chemotherapy (and ?prophylaxis) of HIV infections.
This has brought the total of licensed anti-HIV drugs to nineteen.
(iii) Yet other compounds, acting by novel mechanisms, have recently been identified as anti-HIV agents that seem worthy of further (pre)clinical development: cell receptor CD4 downmodulators (i.e.
cyclotriazadisulfonamides), viral envelope gp120-binding agents such as plant lectins and glycopeptide antibiotics, HIV integrase inhibitors such as the pyranodipyrimidine V-165, and two new classes of compounds (i.e.
Taken together, it is obvious that in recent years both more diverse and more efficient approaches have become available for the treatment of HIV infections.